JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, cilt.34, sa.2, ss.199-206, 2002 (SCI-Expanded)
Background: Interferon-alpha was the first accepted treatment of chronic hepatitis C. In recent years, adding ribavirin has produced better response rates in adult patients than monotherapy with interferon-alpha. Whether adding ribavirin also improves treatment results in pediatric patients remains unclear.